The Potential and Current Progress of Internalizing Molecules in Targeted Drug Delivery - Intracellular Delivery: Fundamentals and Applications - page 119

Kim, S. S., Garg, H., Joshi, A. & Manjunath, N. (2009c) Strategies for targeted nonviral delivery
of siRNAs in vivo. Trends Mol Med , 15, 491-500.
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D.,
Benz, C. C. & Park, J. W. (2006) Antibody targeting of long-circulating lipidic nanoparticles
does not increase tumor localization but does increase internalization in animal models.
Cancer Res , 66, 6732-40.
Kraus, E., James, W. & Barclay, A. N. (1998) Cutting edge: novel RNA ligands able to bind CD4
antigen and inhibit CD4+ T lymphocyte function. J Immunol , 160, 5209-12.
Kumar, P., Ban, H. S., Kim, S. S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas,
V., Habiro, K., Yang, Y. G., Jeong, J. H., Lee, K. Y., Kim, Y. H., Kim, S. W., Peipp, M., Fey,
G. H., Manjunath, N., Shultz, L. D., Lee, S. K. & Shankar, P. (2008) T cell-specific siRNA
delivery suppresses HIV-1 infection in humanized mice. Cell , 134, 577-86.
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. & Hendrickson, W. A. (1998)
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a
neutralizing human antibody. Nature , 393, 648-59.
Langer, R. (1998) Drug delivery and targeting. Nature , 392, 5-10.
Larson, R. A., Sievers, E. L., Stadtmauer, E. A., Lowenberg, B., Estey, E. H., Dombret, H.,
Theobald, M., Voliotis, D., Bennett, J. M., Richie, M., Leopold, L. H., Berger, M. S., Sherman,
M. L., Loken, M. R., van Dongen, J. J., Bernstein, I. D. & Appelbaum, F. R. (2005) Final
report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with
CD33-positive acute myeloid leukemia in first recurrence. Cancer , 104, 1442-52.
Lee, H., Jang, I. H., Ryu, S. H. & Park, T. G. (2003) N-terminal site-specific mono-PEGylation of
epidermal growth factor. Pharm Res , 20, 818-25.
Lee, H., Kim, T. H. & Park, T. G. (2002) A receptor-mediated gene delivery system using strepta-
vidin and biotin-derivatized, pegylated epidermal growth factor. J Control Release , 83,
109-19.
Lee, H. & Park, T. G. (2002) Preparation and characterization of mono-PEGylated epidermal
growth factor: evaluation of in vitro biologic activity. Pharm Res , 19, 845-51.
Levy-Nissenbaum, E., Radovic-Moreno, A. F., Wang, A. Z., Langer, R. & Farokhzad, O. C. (2008)
Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol , 26, 442-9.
Li, N., Larson, T., Nguyen, H. H., Sokolov, K. V. & Ellington, A. D. (2010) Directed evolution of
gold nanoparticle delivery to cells. Chem Commun (Camb) , 46, 392-4.
Li, S., Tan, Y., Viroonchatapan, E., Pitt, B. R. & Huang, L. (2000) Targeted gene delivery to pul-
monary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol , 278,
L504-11.
Li, S. D. & Huang, L. (2006) Targeted delivery of antisense oligodeoxynucleotide and small
interference RNA into lung cancer cells. Mol Pharm , 3, 579-88.
Lim, D. W., Yeom, Y. I. & Park, T. G. (2000) Poly(DMAEMA-NVP)-b-PEG-galactose as gene
delivery vector for hepatocytes. Bioconjug Chem , 11, 688-95.
Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R. & Bander, N. H.
(1998) Constitutive and antibody-induced internalization of prostate-specific membrane anti-
gen. Cancer Res , 58, 4055-60.
Liu, Z., Sun, X., Nakayama-Ratchford, N. & Dai, H. (2007a) Supramolecular chemistry on water-
soluble carbon nanotubes for drug loading and delivery. ACS Nano , 1, 50-6.
Liu, Z., Winters, M., Holodniy, M. & Dai, H. (2007b) siRNA delivery into human T cells and
primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl , 46, 2023-7.
Lupold, S. E., Hicke, B. J., Lin, Y. & Coffey, D. S. (2002) Identification and characterization of
nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-
specific membrane antigen. Cancer Res , 62, 4029-33.
Maeda, H. (2010) Tumor-selective delivery of macromolecular drugs via the EPR effect: back-
ground and future prospects. Bioconjug Chem , 21, 797-802.
Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B. &
Park, J. W. (2005) Epidermal growth factor receptor-targeted immunoliposomes significantly
enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res , 65, 11631-8.